Acid-base monitoring and management

Initial Assessment - The Acid Test

• Initial Labs: VBG/ABG & Basic Metabolic Panel (BMP).
• Core Triad:
  • Metabolic Acidosis: pH < 7.3, HCO₃⁻ < 18 mEq/L.
  • High Anion Gap: > 12. Formula: $Na^+ - (Cl^- + HCO_3^-)$.
  • Ketosis: Positive serum or urine ketones.
• 📌 MUDPILES for differential diagnosis of high anion gap metabolic acidosis.

⭐ A Venous Blood Gas (VBG) is often sufficient for initial pH and bicarbonate monitoring, sparing the patient from a more invasive ABG.

Bicarbonate Therapy - The Fizz Question

Generally avoided. Insulin is the key to stopping ketogenesis and resolving acidosis. Bicarbonate is a temporary fix with significant risks.

• Indication: Reserved for severe metabolic acidosis where pH < 6.9, leading to hemodynamic compromise.

• Risks:
  • Hypokalemia (due to K⁺ shift into cells)
  • Volume overload
  • Left shift of oxyhemoglobin curve (↓ tissue O₂)

⭐ Paradoxical CNS Acidosis: Infused bicarbonate ($HCO_3^−$) is converted to $CO_2$, which readily crosses the blood-brain barrier. This worsens acidosis in the cerebrospinal fluid, potentially leading to cerebral edema and coma.

Monitoring Response - Gap Watching

• Primary Goal: Close the anion gap (AG). Resolution of DKA is defined by AG closure, not just euglycemia or pH normalization.
• Calculation: $AG = Na^+ - (Cl^- + HCO_3^-)$. Normal is < 12 mEq/L.
• Frequency: Monitor serum electrolytes and calculate the gap every 2-4 hours.
• Transition Criteria: Closing the anion gap to < 12 mEq/L is a key criterion for transitioning from IV insulin to subcutaneous insulin.

⭐ As the ketoacidosis resolves, a transient, non-anion gap hyperchloremic metabolic acidosis may emerge. This is due to renal bicarbonate loss and chloride retention from large-volume saline resuscitation and is typically self-limiting.

Resolution Criteria - The Finish Line

• Primary goal is anion gap closure, not just euglycemia. DKA resolves when the following are met:
  • Anion Gap: < 12 mEq/L
  • Blood Glucose: < 200 mg/dL
  • Serum Bicarbonate: ≥ 15 mEq/L
  • Venous pH: > 7.3
• Patient must be clinically stable and able to tolerate oral intake before stopping the insulin infusion.
• Transition Protocol:
  • Administer long-acting subcutaneous insulin 1-2 hours before discontinuing the IV insulin drip to prevent relapse into ketoacidosis.

⭐ The anion gap is the first and most important parameter to normalize in DKA treatment; bicarbonate levels often lag behind. Closing the gap indicates cessation of ketone production.

High-Yield Points - ⚡ Biggest Takeaways

• Anion gap closure is the primary therapeutic endpoint, not pH or bicarbonate level.
• Continue IV insulin until the anion gap normalizes, even if glucose is <200 mg/dL.
• Reserve sodium bicarbonate for severe, life-threatening acidemia (pH < 6.9).
• Monitor the anion gap every 2-4 hours to assess DKA resolution.
• Overlap IV and subcutaneous insulin for 1-2 hours before discontinuing the infusion.
• A transient hyperchloremic non-anion gap metabolic acidosis is common during recovery.